Status:
UNKNOWN
Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI
Lead Sponsor:
Assiut University
Conditions:
ST Elevation Myocardial Infarction
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
Effect of upstream treatment with high intensity statin on the outcome of ST segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention
Detailed Description
Inflammation plays a key role in the occurrence and development of atherosclerosis(.T lymphocytes are among the earliest cells to be recruited into the atherosclerotic plaque.The combination of macrop...
Eligibility Criteria
Inclusion
- STEMI patients eligible for primary PCI presented to Assiut university heart hospital.
Exclusion
- Previous (within 3 months) or current treatment with statins
- Patients with contraindications to statins.
- Patients with cardiogenic shock.
- Patients with acute STEMI not eligible for Primary.
- Patients with other factors affecting leucocytic count such as active infection or leukemia.
- Inability to provide informed consent
Key Trial Info
Start Date :
February 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04754789
Start Date
February 20 2021
End Date
March 1 2021
Last Update
February 15 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.